Inspire Medical Systems, Inc. to Report Third Quarter 2019 Financial Results on November 5, 2019


MINNEAPOLIS, Oct. 08, 2019 (GLOBE NEWSWIRE) — Inspire Medical Systems, Inc. (INSP) (“Inspire”), a medical know-how firm centered on the event and commercialization of progressive and minimally invasive options for sufferers with obstructive sleep apnea, at this time introduced that it’s going to launch monetary outcomes for the third quarter 2019 after the shut of buying and selling on Tuesday, November 5.  Inspire’s administration crew will host a corresponding convention name starting at 5:00 p.m. Eastern Time to focus on the monetary outcomes and up to date enterprise developments.

About Inspire Medical Systems
Inspire is a medical know-how firm centered on the event and commercialization of progressive and minimally invasive options for sufferers with obstructive sleep apnea. Inspire’s proprietary Inspire remedy is the primary and solely FDA-approved neurostimulation know-how that gives a secure and efficient remedy for reasonable to extreme obstructive sleep apnea.

For further details about Inspire, please go to www.inspiresleep.com.

Investor and Media Contact:
Bob Yedid
LifeSci Advisors
encourage@lifesciadvisors.com
646-597-6989

Source link